Category: Health

Gut Bela Launches Gut-First Wellness Movement, Showcases Healthy Ageing with Rahul Singh’s Drive

New Delhi | 30 June 2026

The future of wellness may not begin with vitamins—it begins with the gut. Challenging decades of conventional thinking, Gut Bela has introduced a wellness concept that places gut metabolism at the centre of overall health. To bring this message to life, 86-year-old Rahul Singh, son of the late Khushwant Singh, set out on a non-stop drive from Delhi to Kasauli on Tuesday morning, demonstrating that healthy ageing is not just about living longer, but about remaining energetic, mentally sharp and physically active. Singh says his daily wellness routine includes Gut Bela along with CoviVeda Anti-Ageing Tea, which he has been consuming regularly for the past seven to eight years.

Gut Bela Launches Gut-First Wellness Movement, Showcases Healthy Ageing with Rahul Singh's Drive

 

According to the company, this is not a publicity stunt but an attempt to draw attention to the growing scientific understanding that gut health influences multiple aspects of physical and mental well-being.

What exactly is Gut Bela & CoviVeda?

Gut Bela introduces a new philosophy: Fix the gut to transform the body and mind. Unlike traditional supplements that often deliver limited results, Gut Bela targets gut metabolism, digestion, microbiome balance, and nutrient absorption using a synergistic blend of time-tested Indian herbs and modern nutritional science.

Prithu Nath, founder of Gut Bela and CoviVeda explained:

“For decades, people have chased health through more vitamins. We believe the real starting point is the gut. When digestion and metabolism improve, the body naturally absorbs nutrients better, balances hormones, boosts energy, supports libido, sharpens the mind, and promotes a younger, more vibrant you. Gut Bela brings together ancient Ayurvedic wisdom and emerging microbiome research to deliver real, noticeable results—often within two weeks.”

While CoviVeda is designed to support lung and respiratory health, complementing a holistic wellness approach by promoting overall well-being alongside daily health routines.

The Science of Gut Vitality

Modern research confirms the gut as the body’s “second brain,” influencing far more than digestion:

* Gut-Brain Axis: Supports neurotransmitter production (like serotonin), reduces brain fog, and enhances mental clarity, focus, and mood.
* Metabolism & Energy: Improves nutrient absorption, regulates blood sugar, and fights fatigue for sustained all-day vitality.
* Hormone & Libido Health: Helps balance hormones and reduces inflammation that can dampen drive.
* Immunity & Healthy Ageing: Promotes regular bowel movements, lowers systemic inflammation, and supports overall rejuvenation.

Gut Bela is formulated as a 100% natural, gentle daily supplement for constipation relief, digestion, microbiome support, and complete gut vitality—helping users feel lighter, more energetic, and confident.

This initiative aims to spark a broader conversation on preventive health: prioritizing digestive wellness proactively rather than treating symptoms later. Rahul Singh’s energetic journey stands as living proof of what is possible when you put gut health first.

The Gut-Brain Connection

Scientific studies over the past decade have shown that the gut and brain remain in constant communication through neural, hormonal and immune pathways. Improving gut function may help reduce digestive discomfort while supporting clearer thinking, improved mood and sustained energy in many individuals.

Because the digestive system also plays an important role in nutrient absorption and hormone regulation, maintaining gut health may positively influence overall physical performance, healthy ageing and quality of life.

Driving a Conversation on Healthy Ageing

Speaking before beginning his journey, Rahul Singh said he continues to feel energetic and active even at the age of 86.

“Age should never become the defining factor in how we live. I feel energetic, refreshed and mentally alert. Looking after my gut has become an important part of my daily routine. Along with Gut Bela, I have also been drinking CoviVeda Anti-Ageing Tea every day for the last seven to eight years. Together, they have become part of my wellness routine, and I hope this journey encourages more people to think differently about health and ageing,” he said.

Science and Tradition Together

Prithu Nath said Gut Bela is the result of years of research that combines traditional Indian herbal wisdom with emerging scientific understanding of the human microbiome. He believes that the future of preventive healthcare lies in strengthening the body’s natural systems rather than merely treating symptoms after they appear.

The company said it hopes the campaign will inspire more people to view gut health as the foundation of long-term wellness and healthy ageing, while encouraging a shift towards preventive healthcare backed by both traditional knowledge and modern science. The campaign also highlights Rahul Singh’s long-term commitment to a preventive wellness routine, including his daily consumption of CoviVeda Anti-Ageing Tea for the past seven to eight years alongside his focus on gut health.

Nadda Praises PM Modi’s Push to Strengthen India’s Medical Education System

New Delhi, June 30: BJP National President JP Nadda has lauded Prime Minister Narendra Modi’s vision and leadership in strengthening India’s health sector and medical education ecosystem.

He said that under the Prime Minister’s leadership, the country has witnessed significant expansion in healthcare infrastructure, including an increase in medical colleges, medical seats, and improved access to quality healthcare services.

Nadda noted that ongoing reforms have helped modernise the medical education system, improve healthcare delivery, and address the shortage of trained medical professionals across the country.

He further stated that these initiatives are contributing to a stronger, more resilient health system capable of meeting the country’s growing healthcare needs.

The BJP reiterated its commitment to supporting continued reforms and development in the health and medical education sectors under the leadership of Prime Minister Narendra Modi.

Simplify Genomics and SimonMed Announce Collaboration to Advance Preventive Healthcare Through Integrated Genomics and Imaging

Combining whole genome interpretation with large-scale whole-body MRI to enable a more comprehensive view of human health 

San Diego, CA — June 30, 2026 — Simplify Genomics today announced a collaboration with SimonMed aimed at advancing a more integrated approach to preventive healthcare. By combining SimonMed’s national scale in whole-body MRI with Simplify’s Whole Genome Interpretation and Reporting Platform, the collaboration seeks to provide a more complete picture of human health— helping identify risk earlier, personalize care pathways, and support more proactive health decisions. Across both imaging and genomics, there is growing evidence that early indicators associated with disease may be identified well before they surface in traditional care pathways. Together, these modalities offer complementary perspectives: genomics can provide insight into underlying disease risk, while imaging can help identify existing structural or physiological changes. 

Simplify Genomics has spent years developing and refining its clinical reporting platform as a CAP/CLIA-certified laboratory and has processed in excess of 50,000 whole genomes to date. The platform includes thousands of disease associations and a broad set of pharmacogenomic insights, designed to support clinical interpretation and integration within real-world care settings. 

Paired with SimonMed’s leadership in accessible, AI-enhanced imaging at national scale—including a network of more than 175 imaging centers across the United States —the collaboration creates an opportunity to explore patterns and connections that may not be visible through any single modality alone, supporting earlier insight and helping to inform clinical decision-making. 

“This collaboration reflects a shared vision for the future of healthcare—one that is more proactive, data-driven, and personalized,” said Travis Lacey, CEO of Simplify Genomics. 

“We believe the future of healthcare lies in making advanced preventive insights more accessible and actionable,” said John Simon, CEO of SimonMed. “By combining imaging and genomics, we have an opportunity to help patients and providers better understand health risk earlier and with greater clarity.” The collaboration is progressing rapidly, with additional updates expected in the near future. 

JP Nadda launches WhatsApp-based Ayushman Sarathi chatbot, unified drug registry

June 29: Union Health Minister J.P. Nadda has launched the Ayushman Sarathi WhatsApp chatbot along with a Unified Drug Registry to make healthcare services more accessible and digitally connected.

The WhatsApp chatbot will help citizens easily access information about government health schemes, hospital services, eligibility, and other health-related queries in a simple and quick way.

The Unified Drug Registry will act as a central digital system to track medicines and improve their availability, monitoring, and regulation across the healthcare system.

Officials said the initiative aims to make healthcare services more transparent, efficient, and citizen-friendly by using widely accessible digital platforms.

Govt invites proposals to cut import dependence in medical devices

June 29: The government has invited proposals from industry, startups, academic institutions, research organisations, and innovators to reduce India’s dependence on imported medical devices and strengthen the country’s domestic manufacturing ecosystem.

The initiative aims to identify practical solutions that can accelerate indigenous production, promote innovation, and address critical technology gaps in the medical devices sector. It seeks to encourage the development of high-quality, affordable medical equipment that can meet India’s growing healthcare needs while reducing reliance on overseas suppliers.

Officials said the proposals will help shape policies and support mechanisms to strengthen research and development, encourage investment in advanced manufacturing, and foster collaboration between industry, academia, and government. The move is also expected to improve supply chain resilience, enhance India’s competitiveness in the global medical devices market, and create new opportunities for startups and manufacturers.

The initiative forms part of the government’s broader vision of building a self-reliant healthcare ecosystem under the Atmanirbhar Bharat initiative, ensuring reliable access to critical medical technologies while positioning India as a global hub for medical device innovation and manufacturing.

New laboratory tool opens door to better treatments for rare and deadly melanomas

Researchers have created a powerful new cellular model to study rare tumours that are resistant to immunotherapies. The tool could change how therapies are developed for aggressive melanomas that currently have almost no effective treatment options. 
 

A research team at the University of Turku in Finland have developed a reliable laboratory model to study BAP1-deficient melanomas, which are a rare type of melanoma that evade the immune system once they have metastasized and are universally resistant to current state-of-the-art immunotherapies.

Metastatic BAP1-deficient melanoma is the most common intraocular malignancy in adults, but it remains rare and extremely difficult to treat once it spreads. When the disease reaches the liver, as it does in roughly half of patients, median survival is measured in months. Unlike common melanomas, BAP1-deficient melanomas do not respond to the immune checkpoint therapies that have transformed cancer care over the past decade.

The key driver behind the tumour’s immune evasion is the loss of a gene called BAP1 (BRCA1-associated protein 1). When BAP1 is lost, tumours become more aggressive, grow faster, and suppress the immune cells that would otherwise attack them. BAP1 loss is the most important molecular event in uveal melanoma progression, and it also plays a role in mesothelioma, renal cell carcinoma, and other cancers.

However, scientists have been unable to study the consequences of BAP1 loss properly in the laboratory, because no suitable immune-competent model existed.

Gene editing solved the missing puzzle piece

To address the issue, the research team used CRISPR-Cas9 gene editing to delete BAP1 from normal melanocyte cells, creating a new pre-clinical tumour model that behaves like human BAP1-deficient melanoma in an animal with a fully functioning immune system.

“BAP1 loss is associated with poor prognosis and resistance to immunotherapy in melanoma. Until now, there has been no preclinical model that faithfully reproduces the tumour–immune interactions seen in patients. Our model fills this gap, for the first time, by recapitulating the human tumour immune microenvironment in vivo. This provides a powerful platform to study how BAP1 loss drives immune evasion and to test novel immunotherapy combinations that may overcome treatment resistance,” explains lead researcher of the study, Dr Mona Wang Meng from the University of Turku.

The absence of a proper laboratory model has been one of the biggest bottlenecks slowing down drug development for BAP1-deficient melanoma and related rare tumours. Previous models either lacked a functional immune system, making them useless for immunotherapy studies, or carry too many confounding mutations that obscure the specific role of BAP1.

“The implications go well beyond melanoma. BAP1 loss is a shared vulnerability across several hard-to-treat cancers. This platform allows us, and research groups worldwide, to rationally design and test new immunotherapy combinations — something that simply was not possible before,” says Dr Carlos R. Figueiredo, the Principal Investigator of the study.

The study was published in the journal Communications Biology. It is part of the broader research programme of MIORG within the InFLAMES Research Flagship at the University of Turku, which focuses on harnessing the immune system to fight cancer. 

 

Centre to launch Aarogya Setu 2.0 to boost digital healthcare access

New Delhi, June 2026: The Government of India is set to launch Aarogya Setu 2.0, along with a series of new digital health initiatives aimed at strengthening inclusive and accessible healthcare across the country.

The upgraded platform will focus on providing citizens with enhanced health tracking, real-time medical alerts, telemedicine support, and improved integration with government health services. Officials said the new version will be more user-friendly, secure, and connected with India’s expanding digital health ecosystem.

Alongside Aarogya Setu 2.0, the government is also rolling out additional digital initiatives designed to improve health data management, early disease detection, and access to healthcare services in rural and underserved areas.

Health authorities stated that these initiatives are part of a broader mission to build a digitally empowered and inclusive healthcare system, ensuring better reach, faster response, and improved public health outcomes.

The launch is expected to significantly strengthen India’s digital health infrastructure and support the goal of universal healthcare access.

CM Vijay to Launch Statewide Pulse Polio Campaign in Tamil Nadu

Chennai, June 27: Chief Minister Vijay will launch a statewide Pulse Polio Immunization Campaign in Tamil Nadu on Sunday, reinforcing the government’s commitment to sustaining polio-free status and strengthening child health initiatives across the state.

The campaign aims to ensure 100% immunization coverage for children under the age of five through widespread vaccination drives at hospitals, primary health centres, schools, and designated booths across all districts.

State health officials have made extensive preparations, including setting up immunization booths, mobilizing healthcare workers, and coordinating with local administration to ensure smooth implementation of the drive. Awareness campaigns have also been intensified to encourage maximum participation from parents and guardians.

The Pulse Polio initiative remains a critical public health program, focusing on preventing the re-emergence of poliovirus and maintaining high levels of community immunity. The state government continues to prioritize child health and preventive healthcare through regular immunization efforts.

The Chief Minister’s participation in the launch event underscores the administration’s focus on strengthening public health infrastructure and ensuring the well-being of children across Tamil Nadu.

How Artificial Intelligence is Quietly Transforming Healthcare for Better, Faster, and Safer Care

How Artificial Intelligence is Quietly Transforming Healthcare for Better, Faster, and Safer Care

Artificial Intelligence (AI) is no longer a future concept in healthcare—it is already reshaping how diseases are detected, how treatments are planned, and how hospitals operate every day. From early diagnosis to personalised medicine, AI is helping doctors work faster, reduce errors, and deliver more focused patient care.

What makes this shift important is not just technology, but the way it improves real human lives—by catching illnesses earlier, reducing delays, and making healthcare more accessible and efficient.

1. Earlier, Smarter Detection of Diseases

One of AI’s biggest strengths lies in its ability to detect patterns that are often invisible to the human eye. By analysing scans such as X-rays, MRIs, and CT images, AI systems can identify early signs of diseases like cancer, heart disorders, and neurological conditions.

This early insight allows doctors to begin treatment sooner, often improving recovery chances and reducing complications. In many cases, AI acts as a second set of eyes—supporting doctors in making more confident decisions.

2. Care Designed Around Each Patient

Healthcare is becoming more personalised thanks to AI. Instead of a “one-size-fits-all” approach, AI uses patient history, genetic data, and lifestyle information to help doctors design more targeted treatments.

This means fewer side effects, better outcomes, and treatments that are more closely aligned with each patient’s unique health condition. It is a shift toward truly individualised care.

3. Preventing Illness Before It Becomes Serious

AI is helping healthcare move from treatment to prevention. By studying patterns in health records and real-time data, AI can identify early warning signs of chronic illnesses such as diabetes, hypertension, and heart disease.

This allows doctors to intervene early—before conditions become severe—reducing hospital visits and improving long-term health outcomes.

4. Making Hospitals Run More Smoothly

Behind the scenes, AI is helping hospitals become more efficient. Tasks like appointment scheduling, billing, record management, and insurance processing are increasingly being automated.

This reduces pressure on healthcare staff and gives doctors more time to focus on patients rather than paperwork. It also helps reduce delays and improves overall hospital organisation.

5. Faster Development of New Medicines

Developing new drugs traditionally takes years, but AI is speeding up this process. It can analyse large sets of chemical and biological data to identify promising drug candidates more quickly.

This is especially important for complex diseases, where faster research can lead to life-saving treatments reaching patients sooner.

6. Continuous Health Monitoring Outside Hospitals

With wearable devices and smart sensors, patients can now be monitored even at home. AI continuously tracks vital signs like heart rate, oxygen levels, and blood sugar.

If something unusual is detected, alerts are sent to healthcare providers immediately. This is especially helpful for patients with chronic conditions who need constant monitoring.

7. Virtual Health Support Anytime

AI-powered virtual assistants are making healthcare more accessible. They help patients with reminders, basic health questions, appointment scheduling, and guidance.

This 24/7 support system ensures that patients are never completely disconnected from healthcare assistance, even outside hospital hours.

8. Helping Doctors Make Better Decisions

AI acts as a support system for doctors by analysing patient data and comparing it with global medical research. It provides evidence-based suggestions that help in diagnosis and treatment planning.

This is especially useful in complex cases where multiple treatment options exist.

9. Improving Patient Experience

AI is also making healthcare more patient-friendly. Faster processing, reduced waiting times, and better communication tools improve the overall experience for patients.

With fewer administrative burdens, healthcare providers can spend more meaningful time with patients, improving trust and care quality.

10. Smarter Hospital Management

Hospitals use AI to predict patient inflow, manage staff schedules, and allocate resources more efficiently. This helps avoid overcrowding and ensures better service during peak demand periods.

It also improves planning and reduces stress on healthcare systems.

Conclusion

Artificial Intelligence is not replacing doctors—it is supporting them. It is helping healthcare systems become faster, more accurate, and more human-focused.

By combining technology with medical expertise, AI is shaping a future where healthcare is not only more advanced but also more personal, preventive, and accessible to all.

India Reviews Residual Shelf-Life Norms for Imported Pharmaceuticals

New Delhi, June 26: The government has invited comments and suggestions from stakeholders on the proposed framework concerning residual shelf-life requirements for imported pharmaceutical products, as part of ongoing efforts to strengthen regulatory clarity and ensure the availability of quality medicines in the country.

The consultation exercise aims to review and rationalise existing provisions governing the minimum residual shelf-life required for drugs at the time of import clearance. The objective is to ensure a balanced approach that safeguards patient safety while also improving ease of doing business for the pharmaceutical sector.

Officials said the proposed review seeks to align regulatory requirements with current global practices and supply chain realities, particularly in cases where medicines are imported to meet urgent clinical or public health needs. The initiative is also expected to reduce procedural bottlenecks and improve the efficiency of drug availability in the domestic market.

Stakeholders, including pharmaceutical manufacturers, importers, industry associations, healthcare professionals, and other concerned parties, have been requested to submit their comments and feedback within the stipulated timeframe.

The government will examine all suggestions received during the consultation process before finalising the revised guidelines on residual shelf-life requirements for imported drugs. The updated framework is expected to enhance regulatory transparency while ensuring uninterrupted access to essential medicines.